Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

Journal of Steroid Biochemistry and Molecular Biology

Volumn 80, Issue 4-5, 2002, Pages 411-418

  Ferrari, L ^a   Martinetti, A ^a   Zilembo, N ^a   Pozzi, P ^a   Buzzoni, R ^a   La Torre, I ^a   Gattinoni, L ^a   Catena, L ^a   Vitali, M ^a   Celio, L ^a   Seregni, E ^a   Bombardieri, E ^a   Bajetta, E ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Aromatase; Breast cancer; Growth factors; IGF 1; IGF 2; IGFBP 1; IGFBP 3; Postmenopause

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CONNECTIVE TISSUE GROWTH FACTOR; GROWTH FACTOR; LETROZOLE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; CIRCULATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HUMAN; POSTMENOPAUSE; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ENZYME INHIBITORS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; NITRILES; POSTMENOPAUSE; TIME FACTORS; TRIAZOLES;

EID: 18344366690     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00040-7     Document Type: Article

References (31)

1. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
2. The insulin-like growth factor system as a target in breast cancer
3. Editorial: A novel whey to study effects of insulin-like growth factor-I on mammalian development
4. Activation of estrogen receptor-mediated gene transcription by IGF-1 in human breast cancer cells
5. Effect of growth factors of estrogen mediated gene expression
6. Insulin-like growth factors in human breast cancer
7. Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer
8. Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer
9. Insulin-like growth factor expression in breast cancer epithelium and stroma
10. Stromal influences on breast cancer cell growth
11. Malignant breast epithelium selects for insulin-like growth factor 2 expression in breast stroma: Evidence for paracrine function
12. The role of the insulin-like growth factor system in human cancer
13. Role of the insulin-like growth factor family in cancer development and progression
14. Aromatase activity and interleukin-6 production by normal and malignant breast tissues
15. The interaction of cytokines in regulating oestradiol 17 β-hydroxysteroid dehydrogenase activity in MCF-7 cells
16. Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients
17. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer
18. Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor 1 levels in advanced breast cancer
19. Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer
20. The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 levels
21. ®: A potent and selective fourth-generation aromatase inhibitor
22. Aromatase inhibitors and breast cancer
23. ®), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in post-menopausal women with breast cancer
24. ®) with megestrol acetate in postmenopausal patients with advanced breast cancer
25. Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy
26. A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer
27. Assessment of response to therapy in advanced breast cancer
28. Action of insulin-like growth factors
29. Somatomedin-C and the assessment of growth
30. Effect of short-term fasting on free/dissociable insulin-like growth factor 1 concentrations in normal human serum
31. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma